Skip to main content
. Author manuscript; available in PMC: 2022 Nov 28.
Published in final edited form as: Mod Pathol. 2020 Jul 28;34(1):194–206. doi: 10.1038/s41379-020-0618-9

Figure 3. Kaplan-Meier survival plots of ovarian mucinous borderline tumors (MBOT) and mucinous carcinomas (MOC) stratified by TP53 status using mutation and immunohistochemistry data.

Figure 3.

A, C, E. Progression-free (PFS; A), overall (OS; C), and disease-specific (DSS; E) survival in patients with MBOT. B, D, F. Progression-free (B), overall (D), and disease-specific (F) survival in patients with MOC.